Literature DB >> 19855972

Serum melatonin levels in ankylosing spondilitis: correlation with disease activity.

Kazim Senel1, Tuba Baykal, Meltem Alkan Melikoglu, Akin Erdal, Saliha Karatay, Akar Karakoc, Mahir Ugur.   

Abstract

This study was carried out to determine the serum levels of melatonin (MLT) in patients with ankylosing spondilitis (AS) and to evaluate its correlation with disease activity. We assessed clinical characteristics and labaratory parameters. Serum samples from 36 patients (25 males, 11 females) with active AS and 25 healthy subjects (18 males, 7 females) were collected. MLT levels were measured by enzyme-linked immunosorbent assay, and disease activity of AS was assessed according to the Bath AS disease activity index (BASDAI), the erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP). Then, the results were compared with those from 25 healty controls. The serum levels of MLT were significantly increased in AS patients as compared to healthy controls (p < 0.05). MLT levels were correlated with BASDAI (r = 0.871, p < 0.001) and CRP levels (r = 0.691, p < 0.001), but not with ESR, in patients with AS. Our results suggest a possible role for this immunoregulatory hormone in the disease activity in AS patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19855972     DOI: 10.1007/s00296-009-1223-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  20 in total

1.  Circadian rhythms in RA.

Authors:  M Cutolo; B Seriolo; C Craviotto; C Pizzorni; A Sulli
Journal:  Ann Rheum Dis       Date:  2003-07       Impact factor: 19.103

Review 2.  Nocturnal hormones and clinical rhythms in rheumatoid arthritis.

Authors:  Maurizio Cutolo; Kati Otsa; Oivi Aakre; Alberto Sulli
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

Review 3.  Melatonin: therapeutic and clinical utilization.

Authors:  A Altun; B Ugur-Altun
Journal:  Int J Clin Pract       Date:  2007-02-13       Impact factor: 2.503

4.  Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison.

Authors:  M Cutolo; G J M Maestroni; K Otsa; O Aakre; B Villaggio; S Capellino; P Montagna; L Fazzuoli; T Veldi; T Peets; E Hertens; A Sulli
Journal:  Ann Rheum Dis       Date:  2005-02       Impact factor: 19.103

Review 5.  Melatonin and its influence on immune system.

Authors:  M Szczepanik
Journal:  J Physiol Pharmacol       Date:  2007-12       Impact factor: 3.011

6.  Neuroendocrine alterations in uveitis patients.

Authors:  H A Wollmann; U Pleyer; S Friedel; M Zierhut; H J Thiel; D Gupta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-05       Impact factor: 3.117

7.  Melatonin serum levels in rheumatoid arthritis.

Authors:  A Sulli; G J M Maestroni; B Villaggio; E Hertens; C Craviotto; C Pizzorni; M Briata; B Seriolo; M Cutolo
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

8.  Melatonin levels are decreased in rheumatoid arthritis.

Authors:  S K West; J M Oosthuizen
Journal:  J Basic Clin Physiol Pharmacol       Date:  1992 Jan-Mar

9.  Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin.

Authors:  Caroline M Forrest; Gillian M Mackay; Nicholas Stoy; Trevor W Stone; L Gail Darlington
Journal:  Br J Clin Pharmacol       Date:  2007-05-15       Impact factor: 4.335

Review 10.  A review of the evidence supporting melatonin's role as an antioxidant.

Authors:  R J Reiter; D Melchiorri; E Sewerynek; B Poeggeler; L Barlow-Walden; J Chuang; G G Ortiz; D Acuña-Castroviejo
Journal:  J Pineal Res       Date:  1995-01       Impact factor: 13.007

View more
  4 in total

1.  Serum melatonin level in ankylosing spondylitis: is it increased in active disease?

Authors:  Mohammad Kamal Senna; Shereen Mohamed Olama; Mohammad El-Arman
Journal:  Rheumatol Int       Date:  2011-11-06       Impact factor: 2.631

Review 2.  [Rheumatism, jet lag and the body clock].

Authors:  G Pongratz; R H Straub
Journal:  Z Rheumatol       Date:  2011-06       Impact factor: 1.372

3.  Melatonin levels in premenopausal women with fibromyalgia syndrome.

Authors:  Kazim Senel; Fatih Baygutalp; Tuba Baykal; Akin Erdal; Mahir Ugur
Journal:  Rheumatol Int       Date:  2011-12-23       Impact factor: 2.631

4.  Melatonin attenuates clock gene cryptochrome1, which may aggravate mouse anti-type II collagen antibody-induced arthritis.

Authors:  Jihye Bang; Hyuk Won Chang; Hae-Ra Jung; Chul-Hyun Cho; Ji-An Hur; Sang-Il Lee; Tae Hyun Choi; Sang-Hyon Kim; Eunyoung Ha
Journal:  Rheumatol Int       Date:  2010-11-28       Impact factor: 2.631

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.